NGM Biopharmaceuticals, Inc. (NGM) Financials
Stock symbol NGM is outdated, potentially delisted? Maybe it is available on other exchange?
NGM Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2023 | 168.9 million | 20.2 million |
| Sept. 30, 2023 | 192.2 million | 22.3 million |
| June 30, 2023 | 220.5 million | 28.4 million |
| March 31, 2023 | 258.8 million | 37.9 million |
NGM Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2023 | -23.2 million | 6.3 million |
| Sept. 30, 2023 | -27.5 million | 6.4 million |
| June 30, 2023 | -40.4 million | 7.5 million |
| March 31, 2023 | -42.5 million | 8.5 million |
NGM Net Income
No data available :(
NGM Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2023 | 147.2 million | - | - |
| Sept. 30, 2023 | 166.0 million | - | 1.4 million |
| June 30, 2023 | 193.5 million | - | 2.8 million |
| March 31, 2023 | 231.0 million | - | 4.1 million |
NGM Shares Outstanding
NGM Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2023 | 188000 | 21.4 million | 7.9 million | - |
| Sept. 30, 2023 | 290000 | 22.9 million | 8.7 million | - |
| June 30, 2023 | 104000 | 32.4 million | 9.6 million | - |
| March 31, 2023 | 670000 | 40.9 million | 11.6 million | - |
NGM Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2023 | 165000 | 518000 |
| Sept. 30, 2023 | 582000 | 500000 |
| June 30, 2023 | 1.4 million | 1.1 million |
| March 31, 2023 | 2.2 million | 1.1 million |
NGM
Price: $1.54
52 week price:
Earnings Per Share: -1.73 USD
P/E Ratio: -0.83
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 175000
Market Capitalization: 128.5 million